This indication of a bone-specific phenotype is supported by our finding of significantly induced HO-1 levels in prostate bone tumors, but not the subcutaneous tumors from mice with diet-induced obesity. This evidence concerns the gene HMOX1 and obesity due to melanocortin 4 receptor deficiency.